4//SEC Filing
Legorreta Pablo G. 4
Accession 0001802768-25-000063
CIK 0001802768other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:49 PM ET
Size
18.7 KB
Accession
0001802768-25-000063
Insider Transaction Report
Form 4
Legorreta Pablo G.
DirectorCEO, Chairman of the Board
Transactions
- Award
Class E Ordinary Shares
2025-05-16+13,356,742→ 13,356,742 total(indirect: By LLC)Exercise: $0.00→ Class A Ordinary Shares (13,356,742 underlying) - Other
Class A Ordinary Shares
2025-05-16+530,348→ 882,495 total - Other
Option (Right to Buy)
2025-05-16+857,138→ 857,138 total(indirect: By LLC)Exercise: $0.00→ Class A Ordinary Shares (857,138 underlying)
Holdings
- 460,139(indirect: By LLC)
Class A Ordinary Shares
- 600,000(indirect: By Trust)
Class A Ordinary Shares
- 41,306(indirect: By Trust)
Class A Ordinary Shares
- 6,930(indirect: By Spouse)
Class A Ordinary Shares
- 10,000(indirect: By Son)
Class A Ordinary Shares
- 10,000(indirect: By Daughter)
Class A Ordinary Shares
- 123,310(indirect: By IRRA)
Class A Ordinary Shares
- 118,500(indirect: By IRA)
Class A Ordinary Shares
- 1,040,410(indirect: By Trust)
Class A Ordinary Shares
- 292,190(indirect: By Tata MC 35 Ltd.)
Class A Ordinary Shares
- 901,590(indirect: By Trust)
Class A Ordinary Shares
Footnotes (4)
- [F1]Represents the transfer to the Reporting Person by the RP Management Equity Incentive Plan Trust of Class A Ordinary Shares for no consideration.
- [F2]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class E ordinary shares ("Class E Shares") of Royalty Pharma Holdings Ltd ("RPH") in connection with the consummation of the transactions contemplated by the Membership Interests Purchase Agreement, dated as of January 10, 2025 (as may be amended from time to time, the "Purchase Agreement") between RPH, Royalty Pharma, LLC, RP Management, LLC, the Issuer and certain other parties thereto.
- [F3]Each Class E share will vest in installments over a 5-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis, and there is no expiration date for such conversion.
- [F4]Represents the Reporting Person's right to acquire certain Class E Shares held by other employees of the Issuer and its subsidiaries in the event such Class E Shares are forfeited by such employee.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001507678
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:49 PM ET
- Size
- 18.7 KB